These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 27833083)

  • 1. Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells.
    Guo H; Hu G; Yang Q; Zhang P; Kuang W; Zhu X; Wu L
    Oncotarget; 2016 Dec; 7(49):81806-81814. PubMed ID: 27833083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
    Huang S; Qing C; Huang Z; Zhu Y
    Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
    Huang JL; Liao Y; Qiu MX; Li J; An Y
    Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of Long Noncoding RNA CCAT2 Inhibits Cellular Proliferation, Invasion, and Epithelial-Mesenchymal Transition in Glioma Cells.
    Zeng J; Du T; Song Y; Gao Y; Li F; Wu R; Chen Y; Li W; Zhou H; Yang Y; Pei Z
    Oncol Res; 2017 Jul; 25(6):913-921. PubMed ID: 27938499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-383 expression regulates proliferation, migration, invasion, and apoptosis in human glioma cells.
    Xu D; Ma P; Gao G; Gui Y; Niu X; Jin B
    Tumour Biol; 2015 Sep; 36(10):7743-53. PubMed ID: 25936342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
    Deng X; Zhao Y; Wu X; Song G
    Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-β signaling pathway.
    Wu ZJ; Li Y; Wu YZ; Wang Y; Nian WQ; Wang LL; Li LC; Luo HL; Wang DL
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):706-714. PubMed ID: 28272713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of Long Noncoding RNA Small Nucleolar RNA Host Gene 18 Promotes Radioresistance of Glioma by Repressing Semaphorin 5A.
    Zheng R; Yao Q; Ren C; Liu Y; Yang H; Xie G; Du S; Yang K; Yuan Y
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):877-887. PubMed ID: 27788958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of linc-OIP5 inhibits proliferation and migration of glioma cells through down-regulation of YAP-NOTCH signaling pathway.
    Hu GW; Wu L; Kuang W; Chen Y; Zhu XG; Guo H; Lang HL
    Gene; 2017 Apr; 610():24-31. PubMed ID: 28189759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling.
    Wang Y; Wang Y; Li J; Zhang Y; Yin H; Han B
    Cancer Lett; 2015 Oct; 367(2):122-8. PubMed ID: 25813405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA Linc00320 inhibits glioma cell proliferation through restraining Wnt/β-catenin signaling.
    Tian S; Liu W; Pan Y; Zhan S
    Biochem Biophys Res Commun; 2019 Jan; 508(2):458-464. PubMed ID: 30503496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Intergenic Noncoding RNA 00152 Promotes Glioma Cell Proliferation and Invasion by Interacting with MiR-16.
    Chen X; Li D; Gao Y; Tang W; Iw L; Cao Y; Hao B
    Cell Physiol Biochem; 2018; 46(3):1055-1064. PubMed ID: 29669323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G
    Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells.
    Xu C; He T; Li Z; Liu H; Ding B
    Biomed Pharmacother; 2017 Nov; 95():1504-1513. PubMed ID: 28946213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA H19 regulates the development of gliomas through the Wnt/β-catenin signaling pathway.
    Guan N; Wang R; Guo WS; Lai YJ; Zhang YD; Cheng YY
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4243-4253. PubMed ID: 31173296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma.
    Ruan R; Zhao XL
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2978-2984. PubMed ID: 29863240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186.
    Zheng J; Li XD; Wang P; Liu XB; Xue YX; Hu Y; Li Z; Li ZQ; Wang ZH; Liu YH
    Oncotarget; 2015 Sep; 6(28):25339-55. PubMed ID: 26231038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
    Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
    Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a.
    Ma CC; Xiong Z; Zhu GN; Wang C; Zong G; Wang HL; Bian EB; Zhao B
    J Exp Clin Cancer Res; 2016 Jun; 35(1):90. PubMed ID: 27267902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of long non‑coding RNA CCAT2 suppresses the progression of thyroid cancer by inhibiting the Wnt/β‑catenin pathway.
    Xin S; Ye X
    Int J Mol Med; 2020 Dec; 46(6):2047-2056. PubMed ID: 33125134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.